CARLOS MARTINEZ: Open Payments
NPI 1649895160 · RANDOLPH, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,097 in 82 payments from 15 companies in 2025. Trend: 2023 $901 · 2024 $1,301 · 2025 $1,097
Food & beverage: $1,026Education: $71
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $288 |
| Amgen Inc. | 19 | $168 |
| Janssen Biotech, Inc. | 7 | $167 |
| LEO Pharma Inc. | 5 | $90 |
| Lilly USA, LLC | 4 | $84 |
| PFIZER INC. | 5 | $81 |
| Galderma Laboratories, L.P. | 2 | $38 |
| GENZYME CORPORATION | 2 | $33 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
Products named: TREMFYA, Otezla, SKYRIZI, RINVOQ, ADBRY, CIBINQO, DUPIXENT, EBGLYSS.
Industry payments across NJ — which companies pay providers there.
